Copanlisib Impurity 2 | CAS 2698-69-3 - Request Quote
Copanlisib Impurity 2
| SZ CAT No: | SZ-C104005 |
| CAS No | 2698-69-3 |
| Mol.F. | C10H9NO6 |
| Mol.Wt. | 239.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Copanlisib Impurity 2 is chemically 4-Formyl-2-methoxy-3-nitrophenyl acetate. Copanlisib Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Copanlisib Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Copanlisib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2698-69-3
Purchase 2698-69-3
Order 2698-69-3
Enquire 2698-69-3
price of 2698-69-3
2698-69-3 Supplier
2698-69-3 Manufacturer
2698-69-3 Exporter
buy high quality Copanlisib Impurity 2
Purchase Copanlisib Impurity 2
Copanlisib Impurity 2 suppliers
Copanlisib Impurity 2 manufacturers
Copanlisib Impurity 2 price
Order Copanlisib Impurity 2
Enquire Copanlisib Impurity 2
Copanlisib Impurity 2 cost
Copanlisib Impurity 2 Supplier
Copanlisib Impurity 2 Distributor
Copanlisib Impurity 2 for Method Validation
Copanlisib Reference Standard
Copanlisib Impurity 2 for ANDA Filing
Copanlisib Impurity 2 for Forced Degradation Studies
Copanlisib Impurity 2 Identification Standards
Copanlisib Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


